Publications by authors named "Allison Berger"

Claim this Profile
P
Phase 1b Study of Dazostinag plus Pembrolizumab after Hypofractionated Radiotherapy in Patients with Select Advanced Solid Tumors.
Benjamin T Cooper, Wade T Iams, David B Page, Yuan Yuan, Naamit K Gerber, Allison Berger

Cancer Res Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A First-In-Human Study of the SUMOylation Inhibitor Subasumstat in Patients with Advanced/Metastatic Solid Tumors or Relapsed/Refractory Hematologic Malignancies.
Dejan Juric, Daniel Anderson, Afshin Dowlati, Jordi Rodon, Iwona Lugowska, Allison Berger

Cancer Res Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of SUMOylation Induces Adaptive Antitumor Immunity against Pancreatic Cancer through Multiple Effects on the Tumor Microenvironment.
Suna Erdem, Hyojae James Lee, Jayanth Surya Narayanan Shankara Narayanan, Mohottige Don Neranjan Tharuka, Jorge De la Torre, Allison J Berger

Mol Cancer Ther· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATF3 and CH25H regulate effector trogocytosis and anti-tumor activities of endogenous and immunotherapeutic cytotoxic T lymphocytes.
Zhen Lu, Noreen McBrearty, Jinyun Chen, Vivek S Tomar, Hongru Zhang, Allison Berger

Cell Metab· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment.
Jonathan M J Derry, Connor Burns, Jason P Frazier, Emily Beirne, Marc Grenley, Allison Berger

Clin Cancer Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T Cell-intrinsic Immunomodulatory Effects of TAK-981 (Subasumstat), a SUMO-activating Enzyme Inhibitor, in Chronic Lymphocytic Leukemia.
Vi Lam, Carly Roleder, Tingting Liu, Nur Bruss, Scott Best, Allison J Berger

Mol Cancer Ther· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologic targeting of Nedd8-activating enzyme reinvigorates T-cell responses in lymphoid neoplasia.
Xiaoguang Wang, Canping Chen, Dan Vuong, Sonia Rodriguez-Rodriguez, Vi Lam, Allison Berger

Leukemia· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection of Regulatory T Cells from Fragility and Inactivation in the Tumor Microenvironment.
Hongru Zhang, Vivek S Tomar, Jinyang Li, Raghavendra Basavaraja, Fangxue Yan, Allison Berger

Cancer Immunol Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATF3 and CH25H regulate effector trogocytosis and anti-tumor activities of endogenous and immunotherapeutic cytotoxic T lymphocytes.
Zhen Lu, Noreen McBrearty, Jinyun Chen, Vivek S Tomar, Hongru Zhang, Allison Berger

Cell Metab· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolism and Disposition of [C]Pevonedistat, a First-in-Class NEDD8-Activating Enzyme Inhibitor, after Intravenous Infusion to Patients with Advanced Solid Tumors.
Jayaprakasam Bolleddula, Hao Chen, Lawrence Cohen, Xiaofei Zhou, Sandeepraj Pusalkar, Allison Berger

Drug Metab Dispos· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Empathy without sympathy": An analysis of support-related preferences among young adult cancer survivors.
Katie Darabos, Allison J Berger, Jennifer S Ford

J Psychosoc Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The SUMOylation inhibitor subasumstat potentiates rituximab activity by IFN1-dependent macrophage and NK cell stimulation.
Akito Nakamura, Stephen Grossman, Keli Song, Kristina Xega, Yuhong Zhang, Allison Berger

Blood· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-Related Decision-Making Among Adolescents, Young Adults, Caregivers, and Oncology Providers.
Katie Darabos, Allison J Berger, Lamia P Barakat, Lisa A Schwartz

Qual Health Res· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigations from the Belly of the Beast: N-Terminally Labeled Incretin Peptides That Are Both Potent Receptor Agonists and Stable to Protease Digestion.
Allison Ann Berger, Jakob Leppkes, Beate Koksch

ACS Cent Sci· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulatory effects of pevonedistat, a NEDD8-activating enzyme inhibitor, in chronic lymphocytic leukemia-derived T cells.
Scott Best, Vi Lam, Tingting Liu, Nur Bruss, Adam Kittai, Allison Berger

Leukemia· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiomics Analysis Provides Insight into the Laboratory Evolution of toward the Metabolic Usage of Fluorinated Indoles.
Federica Agostini, Ludwig Sinn, Daniel Petras, Christian J Schipp, Vladimir Kubyshkin, Allison Ann Berger

ACS Cent Sci· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Catalytically Active Peptide-Gold Nanoparticle Conjugates: Prospecting for Artificial Enzymes.
Dorian J Mikolajczak, Allison A Berger, Beate Koksch

Angew Chem Int Ed Engl· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Potential of MLN3651 in Combination with Selumetinib as a Treatment for Merlin-Deficient Meningioma.
Jade Lyons Rimmer, Emanuela Ercolano, Daniele Baiz, Mahindra Makhija, Allison Berger

Cancers (Basel)· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coassembly Generates Peptide Hydrogel with Wound Dressing Material Properties.
Chaitanya Kumar Thota, Allison A Berger, Laura Elomaa, Chaunxiong Nie, Christoph Böttcher

ACS Omega· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologic inhibition of the ubiquitin-activating enzyme induces ER stress and apoptosis in chronic lymphocytic leukemia and ibrutinib-resistant mantle cell lymphoma cells.
Scott Best, Tingting Liu, Nur Bruss, Adam Kittai, Allison Berger

Leuk Lymphoma· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ubiquitin-activating enzyme inhibition induces an unfolded protein response and overcomes drug resistance in myeloma.
Junling Zhuang, Fazal Shirazi, Ram Kumar Singh, Isere Kuiatse, Hua Wang, Allison Berger

Blood· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of the selective small-molecule UBA1 inhibitor, TAK-243, in acute myeloid leukemia.
Samir H Barghout, Parasvi S Patel, Xiaoming Wang, G Wei Xu, Simon Kavanagh, Allison Berger

Leukemia· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting ubiquitin-activating enzyme induces ER stress-mediated apoptosis in B-cell lymphoma cells.
Scott Best, Taylor Hashiguchi, Adam Kittai, Nur Bruss, Cody Paiva, Allison Berger

Blood Adv· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deciphering the Fluorine Code-The Many Hats Fluorine Wears in a Protein Environment.
Allison Ann Berger, Jan-Stefan Völler, Nediljko Budisa, Beate Koksch

Acc Chem Res· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pevonedistat, a Nedd8-activating enzyme inhibitor, sensitizes neoplastic B-cells to death receptor-mediated apoptosis.
Cody Paiva, J Claire Godbersen, Taylor Rowland, Olga V Danilova, Christopher Danes, Allison Berger

Oncotarget· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis